Virax Biolabs Group Limited

Historical 13F Holders

Symbol
VRAX
CUSIP
G9495L125
All holders as of
Q1 2026
Type
Equity
Class
SHS NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for G9495L125 since 12/18/2024, largest first.

Filer % of Class Filed
Foster James Alexander Cunliffe 13G/A 8.3% 10/29/2025
Event 3/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Armistice Capital, LLC 13G/A
4.99% 5/15/2026
Event 3/31/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 3 920 k $202 k
2025 Q4 5 35.0 k $12.1 k
2025 Q3 4 94.8 k $57.0 k
2025 Q2 3 35.2 k $28.6 k
2025 Q1 5 63.1 k $71.5 k
2024 Q4 8 63.0 k $141 k
2024 Q3 6 218 k $424 k
2024 Q2 8 70.8 k $81.8 k
2024 Q1 4 17.5 k $12.5 k
2023 Q4 5 134 k $195 k